ReviveMed Analysis: $6M Raised
What is ReviveMed?
AI-enabled precision medicine using metabolites
Location
Cambridge, United States
Employees
11-50
Founded
2019
Product Features & Capabilities
- AI-based platform for metabolomics
- Digital metabolic twins for obesity
- Predictive models for immunotherapy response
- Multi-modal metabolomics data analysis
- Virtual patient simulations for clinical trials
Use Cases
Predict metabolic health risks beyond BMI; Identify patients likely to benefit from immunotherapy; Simulate clinical trial outcomes with virtual patients; Analyze blood metabolites for cancer treatment insights; Develop targeted therapeutic strategies based on metabolomics
How much ReviveMed raised
Funding - $6M
Other Considerations
Developed at MIT and published in Nature Methods; Recognized for first-in-class generative models in metabolomics; Collaborations with various healthcare and research institutions
See something that needs updating? Suggest edits to this profile.